Complement component 1 Q subcomponent-binding protein, mitochondrial
Definition:
References:
-
[1]. K Joseph, et al. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8552-7. [Content Brief]
[2]. K Joseph, et al. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Clin Immunol. 1999 Sep;92(3):246-55. [Content Brief]
[3]. Yong-Hui Zheng, et al. Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells. Nat Cell Biol. 2003 Jul;5(7):611-8. [Content Brief]
[4]. Lijuan Xu, et al. Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1530-5. [Content Brief]
[5]. L Braun, et al. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J. 2000 Apr 3;19(7):1458-66. [Content Brief]
[6]. Xiaodong Feng, et al. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol. 2002 Mar 1;168(5):2441-8. [Content Brief]
[7]. L E Leigh, et al. C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. Biochem J. 1998 Feb 15;330 ( Pt 1)(Pt 1):247-54. [Content Brief]
[8]. Michael Marino, et al. GW domains of the Listeria monocytogenes invasion protein InlB are SH3-like and mediate binding to host ligands. EMBO J. 2002 Nov 1;21(21):5623-34. [Content Brief]
[9]. Kinga K Hosszu, et al. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood. 2012 Aug 9;120(6):1228-36. [Content Brief]
[10]. D J Kittlesen, et al. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest. 2000 Nov;106(10):1239-49. [Content Brief]
[11]. Lijia Huang, et al. Human p32 is a novel FOXC1-interacting protein that regulates FOXC1 transcriptional activity in ocular cells. Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5243-9. [Content Brief]
[12]. T Nguyen, et al. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect Immun. 2000 Apr;68(4):2061-8. [Content Brief]
[13]. Zsuzsa Vegh, et al. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. Mol Immunol. 2006 Mar;43(9):1402-7. [Content Brief]
[14]. H Herwald, et al. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. J Biol Chem. 1996 May 31;271(22):13040-7. [Content Brief]
[15]. S K Petersen-Mahrt, et al. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J. 1999 Feb 15;18(4):1014-24. [Content Brief]
[16]. Chiara Agostinis, et al. An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. J Immunol. 2010 Oct 1;185(7):4420-9. [Content Brief]
[17]. Gitanjali Yadav, et al. Evidence for inhibitory interaction of hyaluronan-binding protein 1 (HABP1/p32/gC1qR) with Streptococcus pneumoniae hyaluronidase. J Biol Chem. 2009 Feb 6;284(6):3897-905. [Content Brief]
[18]. Stephen N Waggoner, et al. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol. 2005 Oct 1;175(7):4706-14. [Content Brief]
[19]. Stephen N Waggoner, et al. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol. 2007 Dec;82(6):1407-19. [Content Brief]
[20]. Chandrani Chattopadhyay, et al. Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro. Nucleic Acids Res. 2004 Jul 8;32(12):3632-41. [Content Brief]
[21]. René G Feichtinger, et al. Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies. Am J Hum Genet. 2017 Oct 5;101(4):525-538. [Content Brief]
[22]. R A Pixley, et al. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore). Thromb Haemost. 2011 Jun;105(6):1053-9. [Content Brief]
[23]. Harunori Yoshikawa, et al. Splicing factor 2-associated protein p32 participates in ribosome biogenesis by regulating the binding of Nop52 and fibrillarin to preribosome particles. Mol Cell Proteomics. 2011 Aug;10(8):M110.006148. [Content Brief]
[24]. Ketha V Krishna Mohan, et al. The N-terminal conserved domain of rubella virus capsid interacts with the C-terminal region of cellular p32 and overexpression of p32 enhances the viral infectivity. Virus Res. 2002 May 10;85(2):151-61. [Content Brief]